Stephen Sundquist, Executive Director, 3CTN

Stephen has over 25 years of experience in clinical trials and health programs’ leadership. His clinical research expertise includes roles in pharma, CRO and academic settings involving the conduct of Phase 1-3b drug, biologic, and device trials across a wide range of therapeutic areas. In his role as Executive Director for the Canadian Cancer Clinical Trials Network (3CTN), Stephen is responsible for leading initiatives designed to improve equitable trial access, patient accrual as well as the efficient, high-quality conduct of academic cancer clinical trials led by the nearly 60 Network Cancer Centres across Canada.